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ABSTRACT In somatic mammalian cells, homologous
recombination is a rare event. To study the effects of chro-
mosomal breaks on frequency of homologous recombination,
site-specific endonucleases were introduced into human cells
by electroporation. Cell lines with a partial duplication within
the HPRT (hypoxanthine phosphoribosyltransferase) gene
were created through gene targeting. Homologous, intrachro-
mosomal recombination between the repeated regions of the
gene can reconstruct a functioning, wild-type gene. Treatment
of these cells with the restriction endonuclease Xba I, which
has a recognition site within the repeated region of HPRT
homology, increased the frequency of homologous recombi-
nation by more than 10-fold. Recombination frequency was
similarly increased by treatment with the rare-cutting yeast
endonuclease PI-Sce I when a cleavage site was placed within
the repeated region of HPRT. In contrast, four restriction
enzymes that cut at positions either outside of the repeated
regions or between them produced no change in recombina-
tion frequency. The results suggest that homologous recom-
bination between intrachromosomal repeats can be specifi-
cally initiated by a double-strand break occurring within
regions of homology, consistent with the predictions of a
double-strand-break-repair model.
Rates of homologous recombination at any given locus in
somatic mammalian cells are generally low, on the order of
10-8 to 10-5 per cell per generation, and seem to vary
somewhat from locus to locus within a genome (1). Similarly,
frequencies of gene targeting are usually low and have varied
greatly from locus to locus (for representative citations, see ref.
2). The basis for the variability and low frequency is not clear.
From studies in bacteria and fungi, the idea has emerged that
homologous recombination is often a response to DNA dam-
age in the form of breaks across one or both strands of the
DNA duplex. This has been the basis of mechanistic models for
recombination proposed by Meselson and Radding (3),
Resnick (4), and Szostak et al. (5). Many of the central
predictions of these models have been borne out by experi-
ments in yeast (Saccharomyces cerevisiae). Most notable is that
introduction of DNA double-strand breaks within a given
chromosomal locus can specifically increase the frequency of
homologous recombination at that locus. Natural examples of
this in yeast are the initiation of mating-type switch by HO
endonuclease and the movements of mobile introns that
encode "homing endonucleases" such as I-Sce I, I-Sce II, and
PI-Sce I.
In each instance, homologous recombination in the form of
gene conversion is triggered by an endonuclease that induces
a double-strand break in the recipient locus (6-10). The
importance of double-strand breaks for the initiation of ho-
mologous recombination in yeast has been extended and
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generalized by constructing strains in which cleavage sites for
the HO or I-Sce I endonucleases have been placed within test
loci at other chromosomal locations or on extrachromosomal
plasmids. Endonuclease expression in such strains sharply
elevates the frequency of homologous recombination at the test
loci (11-15).
More recently, the I-Sce I endonuclease of yeast has been
expressed in mammalian cells and shown to stimulate homol-
ogous recombination between transfected extrachromosomal
DNA substrates (16) or between a transfected substrate and a
chromosomal locus (17, 18). In the work reported here,
bacterial restriction endonucleases and the PI-Sce I endonu-
clease of yeast have been introduced into immortalized human
fibroblasts by electroporation to determine their effects on
frequency of homologous recombination between tandemly
repeated regions within a chromosomal locus, the HPRT
(hypoxanthine phosphoribosyltransferase) gene.
MATERIALS AND METHODS
Tissue Culture. All cell lines were derived from the human
fibrosarcoma line HT1080 (19) (ATCC no. CCL121). Tissue
culture media, antibiotics, and selective drugs were obtained
from Sigma. For routine passage and expansion, cells were
grown in Dulbecco's modified Eagle's medium (DMEM)
supplemented with 9% fetal calf serum (JRH Biosciences,
Lenexa, KS), penicillin (60 ,tg/ml), streptomycin (100 ,ug/ml),
and selective drugs as described below. In enzyme-
electroporation experiments, cells were placed in MCDB302
medium (20), supplemented with serum and antibiotics as
above to improve the cloning efficiency of HT1080 cells.
Cultures were grown at 37°C, under a humidified atmosphere
with 5% C02, in plastic tissue culture dishes (Corning).
Gene Targeting. Targeting vectors were made using a 6.9-kb
HindIII fragment of the human HPRT gene, which includes
exons 2 and 3 and contiguous intron sequences (see Fig. 1).
This fragment was inserted at the Hindll polylinker site of
pTZ18R (Pharmacia LKB). A neomycin-resistance cassette
from pMClneopA+ (Stratagene) was inserted between the
Sal I and BamHI polylinker sites of pTZ18R. Small insertions
were then made at an Xho I site within HPRT exon 3. Vector
pE3Hs has a 35-bp insertion with sequence 5'-TCGAGTTAT-
GGGACTACTTCGCGCAACAGTATAAC-3'. Vector
pE3Vs has a 66 bp insertion with sequence 5'-TCGATGAC-
GCCATTATCTATGTCGGGTCCGGAGAAAGAGGTAA-
TGAAATGGCAGAAGTCTTGATGG-3'. Targeting vectors
were introduced by electroporation using a Bio-Rad Gene
Pulser with 0.4-cm gap cuvettes. Cells were trypsinized and
resuspended in phosphate buffered saline (137 mM NaCl/8
mM Na2HPO4/2.7 mM KCl/1.5 mM KH2PO4, pH 7.2) to a
density of 13.3 x 106 cells/ml, and chilled on ice. One electrical
pulse was given at settings of 125 ,uF and 250 V. Cells were
dispersed into chilled DMEM and then plated at 1 x 106 cells
§To whom reprint requests should be addressed.
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per 10-cm dish. For selection of targeted cells, the neomycin
analog G418 was added at 400 j,g/ml 1 day after electropo-
ration; medium was replaced with 6-thioguanine added at 5jug/ml after 6 days.
Introduction of Endonucleases into Cells by Electropora-
tion. Restriction endonucleases and storage buffer ("diluent
buffer A") were obtained from New England Biolabs. PI-Sce
I was expressed in Escherichia coli and purified as described
previously (21). The storage buffer for PI-Sce I was 10 mM
KH2PO4, pH 7.6/50 mM KCl/2.5 mM 2-mercaptoethanol/
50% glycerol.
Electroporations were done using a Bio-Rad Gene Pulser
with 0.4-cm gap cuvettes. Hs-9 and Vs-1 cell lines were
expanded under preselection in 6-thioguanine at 10 jig/ml to
suppress the accumulation of spontaneous HPRT+ recombi-
nants. Preselected cells were trypsinized, washed, and resus-
pended in phosphate-buffered sucrose (7 mM KH2PO4, pH
7.4/1 mM MgCl2/272 mM sucrose) to a density of 8 x 106
cells/ml, and chilled on ice. Chilled cell suspension (150 \l)
was mixed thoroughly in an electroporation cuvette with 50 ,l
of endonuclease in storage buffer or storage buffer alone. One
electrical pulse was given at 125 ,LF and 300 V. The electro-
porated cells were immediately dispersed into chilled medium.
Individual experiments comprised five electroporations from
a single population of harvested cells, four with endonuclease
present at a range of concentrations and one with enzyme
storage buffer only. For selection of HPRT+ recombinants,
cells were plated initially without drugs at densities of 2.5 x
105, 1 X 106, or 4 x 106 cells per 10-cm dish. After 48 hr, the
medium was replaced and hypoxanthine 10-4 M, aminopterine
4 x 10-7 M, thymidine 1.6 x 10-5 M (HAT) was added.
Medium and HAT were replaced again 4 days later. For
determinations of cloning efficiency, cells from each electro-
poration were plated at densities of 250, 1000, or 4000 cells per
10-cm dish and were not refed. Twelve days after electropo-
ration and plating, both sets of plates were fixed and stained,
and cell colonies were counted. Before fixation and staining of
selection dishes, one or a few individual HAT-resistant colo-
nies were transferred to separate dishes for expansion. Prep-
aration of genomic DNA, digestion with restriction endonucle-
ases, Southern blotting, and autoradiography were done by
standard methods (22, 23).
RESULTS
Construction of an HPRT Test Locus in a Human Cell Line.
Gene targeting was used to modify the HPRT gene in HT1080
cells for use as a test locus. Two targeting vectors, pE3Hs and
pE3Vs, were constructed so that their integration at the
chromosomal HPRT locus would produce a partial duplication
within the gene; the repeated regions were separated by
plasmid sequence and a neomycin resistance marker (Fig. 1).
Each targeting vector also includes a small insertion within
HPRT exon 3, containing stop codons that break the HPRT
reading frame. The insertion in vector pE3Vs also contains a
cleavage site for the endonuclease PI-Sce I. Before transfec-
tion, the targeting vectors were linearized by digestion with
Xba I. HT1080 cells were transfected with pE3Hs or pE3Vs,
and after double drug selection for gain of neo function and
loss of HPRT function, multiple targeted clones were isolated.
Their structure was confirmed by Southern blotting and PCR
analysis (data not shown). Individual clones designated Hs-9
and Vs-1 were chosen for the experiments described below.
The partially duplicated HPRT test locus can undergo
homologous recombination, as shown in Fig. 1. A reciprocal
exchange or "crossover" between the tandem repeats can
reverse the targeting to produce a restored, wild-type HPRT
locus from which the repeat and associated plasmid sequences
have been removed. These events can be scored and recovered
for analysis using HAT selection for cells that have regained
HPRT function. They occur spontaneously in both the Hs-9
and the Vs-1 cell lines. We looked for changes in the frequency
of crossovers after treatment of Hs-9 or Vs-1 cells with
endonucleases that cleave specific sites within the HPRT test
locus.
Effects on Recombination of Treatment with Restriction
Enzymes. We examined the effects on recombination of
treatment with five restriction enzymes having sites in the
HPRT test locus (Fig. 1). We chose one enzyme, Xba I, that has
a site within the repeated region of the test locus. We also
chose two enzymes, EcoRV and BspI20I, that cut only outside
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FIG. 1. Construction of an HPRT test locus. An HPRT test locus was created by targeted recombination between vectors pE3Hs or pE3Vs (pE3Vs
is shown) and the wild-type HPRT locus of HT1080 cells. Endonuclease cleavage sites within the test locus are indicated. Nco I and BamHI have
sites within the neo gene, 870 bp and 1160 bp away from its left end. For EcoRV, the nearest site is 7 kb away from the repeated region in the
downstream direction. For Bspl201, the nearest site is 4.5 kb away in the upstream direction.
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of the repeated regions and two enzymes, BamHI and Nco I,
that do not cut within the repeated regions but have sites lying
between the repeats. Hs-9 cells were electroporated with 40,
200, 1000, or 5000 units of restriction enzyme or with enzyme
storage buffer only. The treated cells were plated for scoring
of cloning efficiency and recombination frequency (see Ma-
terials and Methods).
Viability of the electroporated cell populations, as measured
by cloning efficiency, was reduced by any of the five restriction
enzymes relative to cells electroporated with enzyme storage
buffer only (Fig. 2). Relative cloning efficiency declined in a
dose-dependent manner, dropping by 80-95% after treatment
with 5000 units of enzyme. The loss in cell viability presumably
results either directly or indirectly from chromosomal damage
due to endonuclease cleavage (24).
Recombination frequency within the HPRT test locus was
increased by treatment with Xba I (Fig. 3). Frequency in-
creased in a dose-dependent manner to a maximum, after
treatment with 5000 units of Xba I, of more than 11-fold
relative to cells treated with storage buffer only. Of the other
four restriction enzymes tested, EcoRV, Bsp1201, BamHI, and
Nco I, none had any apparent effect on recombination.
Effects of PI-Sce I on Frequency of Recombination. Vs-1 and
Hs-9 cells were electroporated with 4, 20, 100, or 500 units of
PI-Sce I, or with PI-Sce I storage buffer only, and plated for
measurement of cloning efficiency and for selection ofHPRT+
recombinants (see Materials and Methods). In both cell lines,
cloning efficiency trended downward slightly as the amount of
PI-Sce I used increased, but much less dramatically than with
restriction enzymes (Fig. 2). PI-Sce I specifically recognizes
and cleaves a site that spans about 30 bp (10). Some sequence
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FIG. 2. Effects of restriction enzymes or PI-Sce I on viability of
Hs-9 and Vs-1 cells. Cell viability was assessed by a cloning efficiency
assay. For Hs-9 cells electroporated only with restriction enzyme
storage buffer, cloning efficiency was typically -20%. For Vs-1 or Hs-9
cells electroporated with PI-Sce I storage buffer only, cloning effi-
ciency was typically -12%. The relative viability of endonuclease-
treated cells was calculated as the ratio of their cloning efficiency to
that of cells electroporated with storage buffer only and was expressed
as a percentage. Points graphed represent mean relative viabilities for
3 experiments each with Bspl20I and Nco I, for 5 experiments each
with BamHI, EcoRV, and Xba I (in Hs-9 cells), and for 12 experiments
with PI-Sce 1 (4 in Hs-9 cells and 8 in Vs-1 cells). For clarity, error bars
are omitted; however, they were comparable to those shown in Figs.
3 and 4.
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FIG. 3. Relative recombination frequencies in Hs-9 cells electro-
porated with restriction enzymes. Recombination frequency was cal-
culated as the number of HPRT+ colonies scored per million cells
plated for selection, divided by the cloning efficiency of the treated
population. For Hs-9 cell populations electroporated with no restric-
tion enzyme (with storage buffer only), recombination frequencies
averaged 1.8 x 10-4 per viable cell plated. Points graphed represent
mean fold increases for three experiments each with Bspl20I and Nco
I and for five experiments each with BamHI, EcoRV, and Xba I. For
clarity, error bars are shown only for the Xba I data; errors associated
with the other data points are comparable.
variation is tolerated by the enzyme; even so, cleavage sites for
PI-Sce I are probably rare in the human genome. In Vs-1 cells,
which contain a cleavage site within the repeated region of the
HPRT test locus, recombination was stimulated in a dose-
dependent fashion by treatment with PI-Sce I. Frequency of
recombination increased relative to cells treated with storage
buffer only, up to a maximum of nearly 10-fold after treatment
with 500 units (Fig. 4). As a control for nonspecific effects,
PI-Sce I was used in parallel experiments to treat Hs-9 cells,
which have no site in the test locus. No effects on recombi-
nation frequency were detected (Fig. 4).
DNA Analysis of HPRT+ Colonies. Hs-9 or Vs-1 cells that
have recovered HPRT function through homologous recom-
bination should have a locus structure identical to wild type.
DNAs from individual HPRT+ colonies were examined after
EcoRI digestion by Southern blotting, using a probe that
distinguishes between the parental duplication and the wild-
type locus (Fig. 1). Twenty-eight HPRT+ colonies that arose in
the absence of enzyme treatment gave the wild-type pattern
expected for homologous recombinants, as did 71 of 75
colonies that arose after enzyme treatment (Table 1). Twenty-
eight Xba I-treated colonies that gave the wild-type pattern
were also shown by Southern blotting to retain the Xba I site,
as expected for gene reconstruction by homologous recombi-
nation.
Four of the 75 HPRT+ colonies that arose after enzyme
treatment gave Southern patterns that did not correspond to
that expected for homologous recombinants (Table 1). Re-
construction of the HPRT gene in these cells presumably
involved a nonhomologous recombination event. The two such
colonies that arose after PI-Sce I treatment each gave a single,
nonwild-type band on Southern analysis (larger in one case,
smaller in the other), consistent with gene reconstruction
through deletion. The other two colonies gave more complex
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FIG. 4. Recombination frequency in Vs-1 and Hs-9 cells electro-
porated with PI-Sce I. Recombination frequency was calculated as the
number of HPRT+ colonies scored per million cells plated for selec-
tion, divided by the cloning efficiency of the treated population. For
Vs-I cells electroporated without PI-Sce I (with storage buffer only),
recombination frequencies averaged 0.3 x 10-4 per viable cell plated.
For Hs-9 cells electroporated with storage buffer only, recombination
frequencies averaged 1.6 x 10-4 per viable cell plated. Points graphed
represent mean fold increases for eight experiments in Vs-1 cells and
for four experiments in Hs-9 cells. Vs-1 cells have a PI-Sce I cleavage
site in the HPRT test locus; Hs-9 cells do not.
patterns not readily interpretable; they have not been analyzed
further.
DISCUSSION
We have shown that intrachromosomal homologous recombi-
nation can be stimulated in human cell lines by treatment with
site-specific endonucleases. The stimulation appears to be
dependent upon the positioning of cleavage sites within ho-
mology. Recombination was stimulated by the restriction
endonuclease Xba I, which has sites lying within repeated
regions of homology, but was not stimulated by any of four
restriction endonucleases that have sites lying outside the
repeated regions or between them. The rare-cutting yeast
endonuclease PI-Sce I also stimulated recombination when its
cleavage site was placed within one repeat, but had no effect
when its site was not present.
An alternate explanation for the effect of Xba I is that it
frequently cuts both repeats in the test locus, and that the
Table 1. Summary of Southern blot analysis of HPRT' colonies
Cell No. Wild-type Aberrant
Endonuclease* line* analyzed patternt patternt
None Hs-9 14 14 0
Xba I Hs-9 29 28 1
BamHI Hs-9 24 23 1
None Vs- 14 14 0
PI-Sce I Vs-1 22 20 2
*Individual HPRT+ colonies were isolated after electroporation of
Hs-9 and Vs-I cells with or without endonucleases.
tSouthern patterns of EcoRI fragments were classified as matching the
wild-type HPRT locus (expected for gene reconstruction by homol-
ogous recombination) or as aberrant (resulting from other than a
simple homologous event).
outermost ends are then rejoined, with deletion of all sequence
between the two cuts, to reconstruct a functional HPRT gene.
But end joining in mammalian cells is often imprecise (25), and
if reconstruction of the HPRT gene after Xba I cleavage came
about mainly by end joining, then at least some of the resulting
clones would probably fail to recreate an Xba I site at thejunction. That all 28 colonies examined retain the Xba I site is
more consistent with gene reconstruction by homologous
recombination. For PI-Sce I in Vs-1 cells, reconstruction of an
apparently wild-type locus by end joining is not plausible,
because the PI-Sce I site is installed in only one of the repeats
(Fig. 1).
Results with EcoRV, Bspl20I, Nco I, and BamHI suggest
that breaks must occur in the repeated segments to stimulate
homologous recombination. All four enzymes reduce the
viability of a treated cell population in a dose-dependent way,
suggesting that they enter cells and cleave chromosomal DNA.
In addition, electroporation of EcoRV has previously been
shown to cause gross chromosomal rearrangements and mu-
tations at the APRT locus in CHO cells (26). The absence of
stimulation by these enzymes rules out an indirect or nonspe-
cific effect in which chromosomal breaks trigger a global
induction or activation of the enzymatic machinery that carries
out recombinational repair.
That BamHI and Nco I have no effect on the frequency of
HPRT+ colonies is somewhat surprising, because cleavage
between the repeats might be expected to bring about a
reconstruction of the HPRT gene through either of two
potential pathways. One would be a single-strand annealing
pathway, which is one kind of homology-mediated recombi-
nation. If cleavage by BamHI or Nco I between the HPRT
repeats were followed with recision of both ends by a strand-
specific exonuclease, then eventually single-stranded regions
of complementary sequence would be exposed. Annealing of
the complementary strands followed by repair would generate
a perfectly reconstructed, wild-type HPRT locus. Single-strand
annealing is the principal pathway for homologous recombi-
nation between substrates transfected or injected into verte-
brate cells (27-32), and it has also been detected as a pathway
of homologous recombination between repeated chromo-
somal sequences in yeast (33-35). The second potential path-
way involves end joining after exonucleolytic recision of DNA
from the original cleavage site. An event of this kind could
produce an imperfectly reconstructed but nonetheless func-
tional HPRT gene. Mammalian cells are known to be highly
proficient in end joining (25), and chromosomal deletions have
been shown to result from electroporation of mammalian cells
with restriction enzymes (26) or from expression of the yeast
endonuclease I-Sce 1 (17, 36). If such pathways operate in Hs-9
cells, they are not efficient enough to change the overall
frequency ofHPRT+ colonies afterBamHI orNco I treatment.
It may be that the particular BamHI and Nco I sites between
the HPRT repeats are not very accessible to the enzymes, so
that cleavage at these positions is rare. Or it may be that
cleavage is frequent, but end joining usually occurs before
enough recision has taken place to allow reconstruction of a
functional gene.
Two recent reports, from Rouet et al. (17) and Choulika et
al. (18), have described expression of the yeast endonuclease
I-Sce I in mouse cell lines to create site-specific chromosomal
breaks and have shown that the breaks can stimulate homol-
ogous recombination between the chromosome and a trans-
fected targeting vector. In each of these studies, the frequency
of recombination was increased by two to three orders of
magnitude over controls. In our experiments, treatment with
Xba I or PI-Sce I produced only about a 10-fold increase in
homologous recombination frequency. Lukacsovich et al. (36)
have described the direct electroporation of I-Sce I enzyme
together with a targeting vector into mouse cells. Although
cleavage and repair of the chromosomal target took place, no
Genetics: Brenneman et al.
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homologous recombination between the targeting vector and
the chromosomal target was detected. Godwin et al. (37)
electroporated the restriction enzyme PaeR7I into hamster
cells containing defective heteroalleles of a reporter gene, but
detected only nonhomologous repair of the chromosomal
cleavage sites and no homologous recombination between
chromosomes. In our experiments, most of the events recov-
ered are apparently homologous; only a minority seem to have
involved nonhomologous repair. The differences between
these various results may have to do with differences in
recombination substrates, the endonucleases chosen, or the
methods used to introduce endonucleases into the cell.
Our results are consistent with models of Resnick (4) and of
Szostak et al. (5), in which the initial step of homologous
recombination is proposed to be a double-strand break within
one of the homologs that are to recombine. For yeast, it has
become clear that initiation in the form of a double-strand
break can be a rate-determining step in homologous recom-
bination (6, 7, 10-15). The results reported here, particularly
taken together with the results of Rouet et al. (17) and of
Choulika et al. (18), show that initiation by a double-strand
break can have the same importance in mammalian cells.
We wish to thank William F. Morgan for his protocol for electro-
poration of enzymes and Paul Hasty, April Kilburn, Ray Merrihew,
Geoff Sargent, and Karen Vasquez for helpful discussions. This work
was supported by Grants GM38219 and DK42678 from the National
Institutes of Health to J.H.W.
1. Bollag, R. J., Waldman, A. S. & Liskay, R. M. (1989) Annu. Rev.
Genet. 23, 199-225.
2. Hasty, P., Rivera, P. J., Chang, C. & Bradley, A. (1991) Mol. Cell.
Biol. 11, 4509-4517.
3. Meselsoh, M. S. & Radding, C. M. (1975) Proc. Natl. Acad. Sci.
USA 72, 358-361.
4. Resnick, M. A. (1976) J. Theor. Biol. 59, 97-106.
5. Szostak, J. W., Orr-Weaver, T. L., Rothstein, R. J. & Stahl, F. W.
(1983) Cell 33, 25-35.
6. Strathern, J. N., Klar, A. J. S., Hicks, J. B., Abraham, J. A., Ivy,
J. M., Nasmyth, K. A. & McGill, C. (1982) Cell 31, 183-192.
7. Zinn, A. R. & Butow, R. A. (1985) Cell 40, 887-895.
8. Colleaux, L., d'Auriol, L., Betermier, M., Cottarel, G., Jacquier,
A., Galibert, F. & Dujon, B. (1986) Cell 44, 521-533.
9. Wenzlau, J. M., Saldanha, R. J., Butow, R. A. & Perlman, P. S.
(1989) Cell 56, 421-430.
10. Gimble, F. S. & Thorner, J. (1992) Nature (London) 357, 301-
306.
11. Nickoloff, J. A., Chen, E. Y. & Heffron, F. (1986) Proc. Natl.
Acad. Sci. USA 83, 7831-7835.
12. Ray, A., Siddiqi, I., Kolodkin, A. L. & Stahl, F. W. (1988) J. Mol.
Biol. 201, 247-260.
13. Rudin, N. & Haber, J. E. (1988) Mol. Cell. Biol. 8, 3918-3928.
14. Nickoloff, J. A., Singer, J. D. & Heffron, F. (1990) Mol. Cell. Biol.
10, 1174-1179.
15. Plessis, A., Perrin, A., Haber, J. E. & Dujon, B. (1992) Genetics
130, 451-460.
16. Rouet, P., Smih, F. & Jasin, M. (1994) Proc. Natl. Acad. Sci. USA
91, 6064-6068.
17. Rouet, P., Smih, F. & Jasin, M. (1994) Mol. Cell. Biol. 14,
8096-8106.
18. Choulika, A., Perrin, A., Dujon, B. & Nicolas, J. F. (1995) Mol.
Cell. Biol. 15, 1968-1973.
19. Rasheed, S., Nelson-Rees, W. A., Toth, E. M., Arnstein, P. &
Gardner, M. B. (1974) Cancer 33, 1027-1033.
20. Hamilton, W. G. & Ham, R. G. (1977) In Vitro 13, 537-547.
21. Gimble, F. S. & Thorner, J. (1993) J. Biol. Chem. 268, 21844-
21853.
22. Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seid-
man, J. G., Smith, J. A. & Struhl, K. (1989) in Current Protocols
in Molecular Biology (Wiley Interscience, New York).
23. Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989) Molecular
Cloning: A Laboratory Manual (Cold Spring Harbor Lab. Press,
Plainview, NY).
24. Winegar, R. A., Phillips, J. W., Youngblom, J. H. & Morgan,
W. F. (1989) Mutat. Res. 225, 49-53.
25. Roth, D. & Wilson, J. (1988) in Illegitimate Recombination in
Mammalian Cells, eds. Kucherlapati, R. & Smith, G. R. (Am. Soc.
Microbiol., Washington, DC), pp. 621-653.
26. Phillips, J. W. & Morgan, W. F. (1994) Mol. Cell. Biol. 14,
5794-5803.
27. Lin, F. L., Sperle, K. & Sternberg, N. (1984) Mol. Cell. Biol. 4,
1020-1034.
28. Lin, F. L., Sperle, K. & Sternberg, N. (1990) Mol. Cell. Biol. 10,
113-119.
29. Lin, F. L., Sperle, K. & Sternberg, N. (1990) Mol. Cell. Biol. 10,
103-112.
30. Maryon, E. & Carroll, D. (1991) Mol. Cell. Biol. 11, 3278-3287.
31. Maryon, E. & Carroll, D. (1991) Mol. Cell. Biol. 11, 3268-3277.
32. Seidman, M. M. (1987) Mol. Cell. Biol. 7, 3561-3565.
33. Nickoloff, J. A., Singer, J. D., Hoekstra, M. F. & Heffron, F.
(1989) J. Mol. Biol. 207, 527-541.
34. Ozenberger, B. A. & Roeder, G. S. (1991) Mol. Cell. Biol. 11,
1222-1231.
35. Fishman-Lobell, J., Rudin, N. & Haber, J. E. (1992) Mol. Cell.
Biol. 12, 1292-1303.
36. Lukacsovich, T., Yang, D. & Waldman, A. S. (1994) Nucleic
Acids Res. 22, 5649-5657.
37. Godwin, A. R., Bollag, R. J., Christie, D. M. & Liskay, R. M.
(1994) Proc. Natl. Acad. Sci. USA 91, 12554-12558.
3612 Gntc:Benmne l
